Ying‐Ling Chen

816 total citations
16 papers, 630 citations indexed

About

Ying‐Ling Chen is a scholar working on Cellular and Molecular Neuroscience, Neurology and Molecular Biology. According to data from OpenAlex, Ying‐Ling Chen has authored 16 papers receiving a total of 630 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Cellular and Molecular Neuroscience, 10 papers in Neurology and 8 papers in Molecular Biology. Recurrent topics in Ying‐Ling Chen's work include Parkinson's Disease Mechanisms and Treatments (8 papers), Nuclear Receptors and Signaling (4 papers) and Genetic Neurodegenerative Diseases (4 papers). Ying‐Ling Chen is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (8 papers), Nuclear Receptors and Signaling (4 papers) and Genetic Neurodegenerative Diseases (4 papers). Ying‐Ling Chen collaborates with scholars based in Taiwan, Netherlands and Germany. Ying‐Ling Chen's co-authors include Tu‐Hsueh Yeh, Hung‐Li Wang, An-Hsun Chou, Allen H. Li, Pin Ouyang, Chin-Song Lu, Yi‐Hsin Weng, Ching‐Chi Chiu, Ying‐Zu Huang and Chuyu Chen and has published in prestigious journals such as International Journal of Molecular Sciences, Journal of Neurochemistry and Biochemical Pharmacology.

In The Last Decade

Ying‐Ling Chen

16 papers receiving 626 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ying‐Ling Chen Taiwan 14 371 315 272 91 88 16 630
Joanna A. Korecka Netherlands 12 273 0.7× 248 0.8× 208 0.8× 105 1.2× 70 0.8× 14 616
Shilpa Ramaswamy United States 10 409 1.1× 441 1.4× 186 0.7× 110 1.2× 78 0.9× 13 762
Sara Duarte‐Silva Portugal 18 502 1.4× 489 1.6× 200 0.7× 108 1.2× 65 0.7× 38 811
Dena G. Hernandez United States 13 252 0.7× 301 1.0× 481 1.8× 139 1.5× 170 1.9× 15 731
Anthony Crawley United States 9 166 0.4× 233 0.7× 455 1.7× 116 1.3× 105 1.2× 9 677
Zhiping Mi United States 11 295 0.8× 220 0.7× 89 0.3× 131 1.4× 67 0.8× 24 561
Lorena de Mena Spain 15 362 1.0× 197 0.6× 212 0.8× 176 1.9× 71 0.8× 22 626
Victorio M. Pozo Devoto Argentina 11 239 0.6× 169 0.5× 172 0.6× 143 1.6× 67 0.8× 18 498
Angela Britton United States 11 352 0.9× 166 0.5× 361 1.3× 84 0.9× 172 2.0× 13 864
Hey‐Kyeong Jeong South Korea 14 198 0.5× 178 0.6× 134 0.5× 81 0.9× 283 3.2× 16 578

Countries citing papers authored by Ying‐Ling Chen

Since Specialization
Citations

This map shows the geographic impact of Ying‐Ling Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ying‐Ling Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ying‐Ling Chen more than expected).

Fields of papers citing papers by Ying‐Ling Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ying‐Ling Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ying‐Ling Chen. The network helps show where Ying‐Ling Chen may publish in the future.

Co-authorship network of co-authors of Ying‐Ling Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Ying‐Ling Chen. A scholar is included among the top collaborators of Ying‐Ling Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ying‐Ling Chen. Ying‐Ling Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Chiu, Ching‐Chi, Ying‐Ling Chen, Yi‐Hsin Weng, et al.. (2024). Downregulation of Protease Cathepsin D and Upregulation of Pathologic α-Synuclein Mediate Paucity of DNAJC6-Induced Degeneration of Dopaminergic Neurons. International Journal of Molecular Sciences. 25(12). 6711–6711. 3 indexed citations
2.
Wang, Hung‐Li, Ying‐Zu Huang, Yi‐Hsin Weng, et al.. (2020). Alda-1, an activator of ALDH2, ameliorates Achilles tendinopathy in cellular and mouse models. Biochemical Pharmacology. 175. 113919–113919. 23 indexed citations
3.
Chiu, Ching‐Chi, Rou-Shayn Chen, Hua-Chien Chen, et al.. (2019). Upregulated Expression of MicroRNA-204-5p Leads to the Death of Dopaminergic Cells by Targeting DYRK1A-Mediated Apoptotic Signaling Cascade. Frontiers in Cellular Neuroscience. 13. 399–399. 42 indexed citations
4.
Wang, Hung‐Li, Chin-Song Lu, Tu‐Hsueh Yeh, et al.. (2019). Combined Assessment of Serum Alpha-Synuclein and Rab35 is a Better Biomarker for Parkinson's Disease. Journal of Clinical Neurology. 15(4). 488–488. 15 indexed citations
6.
Chiu, Ching‐Chi, Tu‐Hsueh Yeh, Chin-Song Lu, et al.. (2017). PARK14 PLA2G6 mutants are defective in preventing rotenone-induced mitochondrial dysfunction, ROS generation and activation of mitochondrial apoptotic pathway. Oncotarget. 8(45). 79046–79060. 35 indexed citations
7.
Weng, Yi‐Hsin, Chuyu Chen, Ying‐Ling Chen, et al.. (2015). (R1441C) LRRK2 induces the degeneration of SN dopaminergic neurons and alters the expression of genes regulating neuronal survival in a transgenic mouse model. Experimental Neurology. 275. 104–115. 26 indexed citations
8.
Chou, An-Hsun, Ying‐Ling Chen, Ching‐Chi Chiu, et al.. (2015). T1-11 and JMF1907 ameliorate polyglutamine-expanded ataxin-3-induced neurodegeneration, transcriptional dysregulation and ataxic symptom in the SCA3 transgenic mouse. Neuropharmacology. 99. 308–317. 19 indexed citations
9.
Chen, Chuyu, Ying‐Ling Chen, Yi‐Hsin Weng, et al.. (2014). (G2019S) LRRK2 causes early-phase dysfunction of SNpc dopaminergic neurons and impairment of corticostriatal long-term depression in the PD transgenic mouse. Neurobiology of Disease. 68. 190–199. 48 indexed citations
10.
Majumder, Pritha, Yi‐Ting Chen, Cheng‐Chun Wu, et al.. (2012). TDP-43 regulates the mammalian spinogenesis through translational repression of Rac1. Acta Neuropathologica. 124(2). 231–245. 55 indexed citations
11.
Chou, An-Hsun, et al.. (2008). Polyglutamine-expanded ataxin-3 causes cerebellar dysfunction of SCA3 transgenic mice by inducing transcriptional dysregulation. Neurobiology of Disease. 31(1). 89–101. 143 indexed citations
12.
Chen, Ying‐Ling, Allen H. Li, Tu‐Hsueh Yeh, An-Hsun Chou, & Hung‐Li Wang. (2008). Nocistatin and nociceptin exert opposite effects on the excitability of central amygdala nucleus-periaqueductal gray projection neurons. Molecular and Cellular Neuroscience. 40(1). 76–88. 22 indexed citations
13.
Wang, Hung‐Li, et al.. (2007). PINK1 mutants associated with recessive Parkinson’s disease are defective in inhibiting mitochondrial release of cytochrome c. Neurobiology of Disease. 28(2). 216–226. 77 indexed citations
15.
Wang, Hung‐Li, Chia‐Yu Hsu, Pei‐Chen Huang, et al.. (2005). Heterodimerization of opioid receptor‐like 1 and µ‐opioid receptors impairs the potency of µ receptor agonist. Journal of Neurochemistry. 92(6). 1285–1294. 61 indexed citations
16.
Wang, Hung‐Li, Kevin Chih‐Yang Huang, Allen H. Li, et al.. (2005). Two C-terminal amino acids, Ser334 and Ser335, are required for homologous desensitization and agonist-induced phosphorylation of opioid receptor-like 1 receptors. Cellular Signalling. 18(5). 670–678. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026